News Features Year in Review: Physicians Pick the Biggest News of 2018 TCTMD News Team December 29, 2018
News Daily News Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention Michael O'Riordan December 10, 2018
News Daily News FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies Michael O'Riordan December 06, 2018
News Daily News Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts Michael O'Riordan November 23, 2018
News Daily News ‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People Caitlin E. Cox November 15, 2018
News Daily News Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows Michael O'Riordan November 06, 2018
News Daily News Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy Michael O'Riordan October 25, 2018
News Daily News CAC Scoring Is Predictive of Risk Across Races and Ethnicities L.A. McKeown October 16, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Conference News ESC 2018 My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More Shelley Wood September 14, 2018
News Conference News ESC 2018 Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy Michael O'Riordan August 27, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Daily News Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes Michael O'Riordan August 09, 2018
News Daily News Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients L.A. McKeown August 09, 2018
News Daily News After Cardiotoxic Chemo, Less Than Half of Women With Breast Cancer Get Recommended Monitoring Caitlin E. Cox August 06, 2018
News Daily News USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment Michael O'Riordan July 12, 2018
News Daily News ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights Michael O'Riordan July 10, 2018